Background stories of how others approached and experienced their European Horizon funding trajectory.
Bio Base Europe Pilot Plant coordinated the Glaukos project, which answered the call topic published in 2019 of Horizon 2020 Framework Programme ‘Develop bio-based fibres and/or functional molecules to improve the performance of textile products’ under the Framework of the Bio-based Industries Joint Undertaking (BBI JU). The consortium partners took up this challenge by valorising industrial side streams and setting up a circular approach to the textile industry.
Read the full article for detailsThe METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.